Global Radiation Oncology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Code: KNJ1408757 No. of Pages: 111 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Radiation Oncology estimated at US$ 5777.1 million in the year 2022, is projected to reach a revised size of US$ 7830.8 million by 2028, growing at a CAGR of 5.2% during the forecast period 2022-2028. The USA market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Europe market for Radiation Oncology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The global key companies of Radiation Oncology include Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay and Mevion Medical Systems, etc. In 2021, the global top five players had a share approximately % in terms of revenue. Report Scope This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Radiation Oncology companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases. This report also includes a discussion of the major players across each regional Radiation Oncology market. Further, it explains the major drivers and regional dynamics of the global Radiation Oncology market and current trends within the industry. Key Companies Covered In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report: Accuray C. R. Bard Elekta IBA Worldwide Varian Medical Systems Carl Zeiss Meditec iCAD IsoRay Mevion Medical Systems Nordion NTP Radioisotopes Canon Medical Systems Market Segments This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028. Radiation Oncology Segment by Type External Beam Radiation Therapy (EBRT) Brachytherapy Radiation Oncology Segment by Application Blood Cancer (Leukaemia) Breast Cancer Gastrointestinal Cancer Respiratory/Lung Cancer Skin Cancer Other Cancers Key Regions & Countries This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Radiation Oncology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Radiation Oncology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 External Beam Radiation Therapy (EBRT) 1.2.3 Brachytherapy 1.3 Market by Application 1.3.1 Global Radiation Oncology Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Blood Cancer (Leukaemia) 1.3.3 Breast Cancer 1.3.4 Gastrointestinal Cancer 1.3.5 Respiratory/Lung Cancer 1.3.6 Skin Cancer 1.3.7 Other Cancers 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Radiation Oncology Market Size (2017-2028) 2.2 Radiation Oncology Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Radiation Oncology Market Size by Region (2017-2022) 2.4 Global Radiation Oncology Market Size Forecast by Region (2023-2028) 2.5 Global Top Radiation Oncology Countries Ranking by Market Size 3 Radiation Oncology Competitive by Company 3.1 Global Radiation Oncology Revenue by Players 3.1.1 Global Radiation Oncology Revenue by Players (2017-2022) 3.1.2 Global Radiation Oncology Market Share by Players (2017-2022) 3.2 Global Radiation Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Radiation Oncology Revenue 3.4 Global Radiation Oncology Market Concentration Ratio 3.4.1 Global Radiation Oncology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Radiation Oncology Revenue in 2021 3.5 Global Radiation Oncology Key Players Head office and Area Served 3.6 Key Players Radiation Oncology Product Solution and Service 3.7 Date of Enter into Radiation Oncology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Radiation Oncology Breakdown Data by Type 4.1 Global Radiation Oncology Historic Revenue by Type (2017-2022) 4.2 Global Radiation Oncology Forecasted Revenue by Type (2023-2028) 5 Global Radiation Oncology Breakdown Data by Application 5.1 Global Radiation Oncology Historic Market Size by Application (2017-2022) 5.2 Global Radiation Oncology Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Radiation Oncology Revenue by Company (2020-2022) 6.2 North America Radiation Oncology Revenue by Type (2017-2028) 6.3 North America Radiation Oncology Revenue by Application (2017-2028) 6.4 North America Radiation Oncology Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Radiation Oncology Revenue by Company (2020-2022) 7.2 Europe Radiation Oncology Revenue by Type (2017-2028) 7.3 Europe Radiation Oncology Revenue by Application (2017-2028) 7.4 Europe Radiation Oncology Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Radiation Oncology Revenue by Company (2020-2022) 8.2 Asia Pacific Radiation Oncology Revenue by Type (2017-2028) 8.3 Asia Pacific Radiation Oncology Revenue by Application (2017-2028) 8.4 Asia Pacific Radiation Oncology Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Radiation Oncology Revenue by Company (2020-2022) 9.2 Latin America Radiation Oncology Revenue by Type (2017-2028) 9.3 Latin America Radiation Oncology Revenue by Application (2017-2028) 9.4 Latin America Radiation Oncology Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Radiation Oncology Revenue by Company (2020-2022) 10.2 Middle East and Africa Radiation Oncology Revenue by Type (2017-2028) 10.3 Middle East and Africa Radiation Oncology Revenue by Application (2017-2028) 10.4 Middle East and Africa Radiation Oncology Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Accuray 11.1.1 Accuray Company Details 11.1.2 Accuray Business Overview 11.1.3 Accuray Radiation Oncology Products and Services 11.1.4 Accuray Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.1.5 Accuray Radiation Oncology SWOT Analysis 11.1.6 Accuray Recent Developments 11.2 C. R. Bard 11.2.1 C. R. Bard Company Details 11.2.2 C. R. Bard Business Overview 11.2.3 C. R. Bard Radiation Oncology Products and Services 11.2.4 C. R. Bard Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.2.5 C. R. Bard Radiation Oncology SWOT Analysis 11.2.6 C. R. Bard Recent Developments 11.3 Elekta 11.3.1 Elekta Company Details 11.3.2 Elekta Business Overview 11.3.3 Elekta Radiation Oncology Products and Services 11.3.4 Elekta Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.3.5 Elekta Radiation Oncology SWOT Analysis 11.3.6 Elekta Recent Developments 11.4 IBA Worldwide 11.4.1 IBA Worldwide Company Details 11.4.2 IBA Worldwide Business Overview 11.4.3 IBA Worldwide Radiation Oncology Products and Services 11.4.4 IBA Worldwide Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.4.5 IBA Worldwide Radiation Oncology SWOT Analysis 11.4.6 IBA Worldwide Recent Developments 11.5 Varian Medical Systems 11.5.1 Varian Medical Systems Company Details 11.5.2 Varian Medical Systems Business Overview 11.5.3 Varian Medical Systems Radiation Oncology Products and Services 11.5.4 Varian Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.5.5 Varian Medical Systems Radiation Oncology SWOT Analysis 11.5.6 Varian Medical Systems Recent Developments 11.6 Carl Zeiss Meditec 11.6.1 Carl Zeiss Meditec Company Details 11.6.2 Carl Zeiss Meditec Business Overview 11.6.3 Carl Zeiss Meditec Radiation Oncology Products and Services 11.6.4 Carl Zeiss Meditec Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.6.5 Carl Zeiss Meditec Radiation Oncology SWOT Analysis 11.6.6 Carl Zeiss Meditec Recent Developments 11.7 iCAD 11.7.1 iCAD Company Details 11.7.2 iCAD Business Overview 11.7.3 iCAD Radiation Oncology Products and Services 11.7.4 iCAD Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.7.5 iCAD Radiation Oncology SWOT Analysis 11.7.6 iCAD Recent Developments 11.8 IsoRay 11.8.1 IsoRay Company Details 11.8.2 IsoRay Business Overview 11.8.3 IsoRay Radiation Oncology Products and Services 11.8.4 IsoRay Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.8.5 IsoRay Radiation Oncology SWOT Analysis 11.8.6 IsoRay Recent Developments 11.9 Mevion Medical Systems 11.9.1 Mevion Medical Systems Company Details 11.9.2 Mevion Medical Systems Business Overview 11.9.3 Mevion Medical Systems Radiation Oncology Products and Services 11.9.4 Mevion Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.9.5 Mevion Medical Systems Radiation Oncology SWOT Analysis 11.9.6 Mevion Medical Systems Recent Developments 11.10 Nordion 11.10.1 Nordion Company Details 11.10.2 Nordion Business Overview 11.10.3 Nordion Radiation Oncology Products and Services 11.10.4 Nordion Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.10.5 Nordion Radiation Oncology SWOT Analysis 11.10.6 Nordion Recent Developments 11.11 NTP Radioisotopes 11.11.1 NTP Radioisotopes Company Details 11.11.2 NTP Radioisotopes Business Overview 11.11.3 NTP Radioisotopes Radiation Oncology Products and Services 11.11.4 NTP Radioisotopes Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.11.5 NTP Radioisotopes Recent Developments 11.12 Canon Medical Systems 11.12.1 Canon Medical Systems Company Details 11.12.2 Canon Medical Systems Business Overview 11.12.3 Canon Medical Systems Radiation Oncology Products and Services 11.12.4 Canon Medical Systems Radiation Oncology Revenue in Radiation Oncology Business (2017-2022) 11.12.5 Canon Medical Systems Recent Developments 12 Radiation Oncology Market Dynamics 12.1 Radiation Oncology Market Trends 12.2 Radiation Oncology Market Drivers 12.3 Radiation Oncology Market Challenges 12.4 Radiation Oncology Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com